Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas.
Indoco Remedies Limited (INDOCO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The INDOCO share price is ₹217.70 (+1.23% today), with a market capitalisation of ₹20B and a price-to-earnings (P/E) ratio of 63.3. MarketRipple tracks the INDOCO investment thesis, the ripple-chain impact of market events on Indoco Remedies Limited, and the Healthcare sector outlook.
Open
₹221.70
High
₹223.66
Low
₹216.90
Prev. Close
₹215.06
52W High
₹287.80
52W Low
₹162.19
Day range
₹216.90–₹223.66
52-week range
₹162.19–₹287.80
Volume
66K
P/E
63.3
ROE
3.2%
D/E
1.16
Margin
1.7%
Indoco Remedies Limited (NSE: INDOCO) is currently trading at ₹217.70 (+1.23%).
Indoco Remedies Limited's market capitalization is ₹20B.
Indoco Remedies Limited's price-to-earnings (P/E) ratio is 63.3.
Indoco Remedies Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Indoco Remedies Limited currently reads neutral, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.